Suggest
#1 in Business Subscribe Email Print

You are here: Home > Legal > Medical Malpractice > Malpractice - Medical Malpractice Overview

Tags

  • problems
  • companies
  • usfda
  • malpractice suits
  • developing combination

  • Links

  • Child Behavior Problems - How To Use A Stuffed Animal To Get To The Solution
  • What Went Pear Shaped 3 - Lures for Pacific Blue Marlin
  • Risks Of Vegetarianism
  • Suggest - Malpractice - Medical Malpractice Overview

    In this article we're going to do an overview of medical malpractice, what it is and what are the main causes of medical practice.

    Medical malpractice, technic
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    ally and legally defined as "a specific legal term related to lawsuits alleging various different circumstances leading to damage to a patient." To put that int
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    English, medical malpractice is anything where a patient receives poor care from a physician leading to the patient developing problems because of this care.

    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    These malpractice suits, stemming from this improper care, include misdiagnosis, mistreatment and any type of negligence. Not all errors are considered malprac
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    ice because there is always a certain amount of risk involved in medicine, especially when dealing with a patient who has serious medical problems to begin with
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    That is why malpractice suits have to be settled in a court of law because it is not so cut and dried.

    The most common diseases that are usually involved in
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    malpractice suits are breast cancer, lung cancer, colorectal cancer, heart attack and appendicitis. The main cause of these malpractice suits is usually misdia
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    nosis either because the diagnosis was delayed for some reason, such as the equipment required wasn't available or a wrong diagnosis was made. Delays in diagno
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    tic testing too often lead to a patient's death. The severity of these delays explains why the monetary awards, when given, are so large.

    In winning a malprac
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    tice suit there are several factors involved. The first is that the claim itself must be made before the statute of limitations expires. If a patient or the p
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    tient's family (assuming the patient has died) brings up the suit after too much time has passed then the case never even makes it to trial. So speed is probab
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    y the most important element in winning a malpractice suit. The actual statute of limitations varies depending on the type of lawsuit and where the lawsuit tak
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    es place. Each state and country has its own rules.

    The next thing is that malpractice has to be proven. It must be proven that the error, if an error occurr
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    d, was not an error that could have been reasonably avoided. If something unforeseen happens that could not have been accounted for then the likelihood of prov
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    ng malpractice is slim. For example, many surgeries and procedures have risks associated with them and therefore if something were to go wrong malpractice woul
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    d be difficult to prove as long as the patient received what is called "accepted standard of care."

    The problem with many malpractice suits is that in too many
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    cases the patient delayed seeing a doctor about a symptom. Usually they disregard it as just life's everyday aches and pains. Finally the pain gets bad enough
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    that the patient goes to see a doctor and by that time it is either too late to successfully treat the problem or the treatment itself needs to be more severe t
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    han it would have been had the patient seen the doctor right away. This of course leads to a greater risk that the treatment will not be successful. When it's
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    not, the patient or patient's family then sues for malpractice.

    Maybe if both sides were a little more diligent medical malpractice suits wouldn't be so common


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.suggest.org.ua/article/130412/suggest-Malpractice--Medical-Malpractice-Overview.html">Malpractice - Medical Malpractice Overview</a>

    BB link (for phorums):
    [url=http://www.suggest.org.ua/article/130412/suggest-Malpractice--Medical-Malpractice-Overview.html]Malpractice - Medical Malpractice Overview[/url]

    Related Articles:

    Reaching Your Ideal Market

    10 Trade Show Tips

    Generating Free Traffic To Your Website

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com

    Search Exchange Web Portal SpyderMap